UPDATE -- Altimmune Announces Acceptance of HepTcell

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
UPDATE -- Altimmune Announces Acceptance of HepTcell Abstract for Presentation at BSI/NVVI Congress 2016

GAITHERSBURG, Md., Dec. 06, 2016 (GLOBE NEWSWIRE) -- Altimmune, Inc., a clinical stage immunotherapeutic company, today announced that its abstract related to the development of an assay to detect low frequency antigen-specific T cells in HepTcell trial participants was accepted for presentation at the BSI/NVVI Congress 2016 taking place December 6 - 9, 2016 in Liverpool, U.K. HepTcell is Altimmune’s first-in-class T cell-activating immunotherapeutic in development for the treatment of chronic hepatitis B (CHB). A Phase 1 trial is currently underway.

The BSI/NVVI Congress 2016 is a joint collaboration between the British Society for Immunology (BSI) and the Dutch Society for Immunology (NVVI), two of Europe’s most established immunology organizations, to bring together the latest in cutting-edge immunology research.

The poster, entitled, “Development of a cultured ELISpot assay to detect low frequency antigen-specific T cells in PBMC from HBV therapeutic vaccine trial participants," will be presented by V. Motskin on Thursday, December 8, 2016 from 5:30 – 7:30 PM GMT.

About Altimmune Altimmune is a clinical stage immunotherapeutic company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The Company has two proprietary platform technologies, RespirVec and Densigen, each of which has been shown to activate the immune system in distinctly different ways than traditional vaccines. Using these technologies, Altimmune has developed three novel clinical stage product candidates that potentially represent an entirely new approach to harnessing the immune system.

The Company’s most advanced product candidate, NasoVAX, is a Phase 2-ready intranasally-delivered recombinant influenza vaccine offering broad and rapid protection with potential for significant advantages over traditional flu vaccines. The second most advanced product candidate, HepTcell, is being tested as an immunotherapy for patients chronically infected with hepatitis B and has the potential to provide a functional cure. With the support of the U.S. Biomedical Advanced Research and Development Authority, or BARDA, the Company is developing a third product candidate, NasoShield, a first-in-class anthrax vaccine designed to provide rapid, stable protection after one intranasal administration. The Company intends to leverage the RespirVec and Densigen platforms to develop additional product candidates for a variety of indications.

 

Contacts: Bill Enright President and CEO Altimmune, Inc. Phone: 240-654-1450 Email: enright@altimmune.com Investor Relations Stephanie Carrington ICR, Inc. Phone: 646-277-1282 Email: Stephanie.Carrington@icrinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Capricor Faces Lawsuit: Investors Should Take Note

Updated Category News Views 4

Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 0

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Travel Smart: Support Wildlife, Avoid Exploitation

Updated Category News Views 1

Rethink Wildlife Tourism for Ethical Travel You ever stopped to think about what those so-called wildlife attractions are really selling? It’s a feel-good illusion wrapped up in exploitation. Travelers often see animals as part of the backdrop of their holiday stories, but the reality is far from picturesque. Behind the photo ops, there's typically a grim story of...

Continue Reading
ECRI Welcomes Safety Expert Meshkati to Its Board

Updated Category News Views 1

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

Continue Reading
United Imaging's CE Mark Ignites CT Innovation in Europe

Updated Category News Views 5

United Imaging's Big Leap in CT Technology Listen up, folks. United Imaging just got the go-ahead to shake things up in Europe with their dual wide-coverage CT family. We're talking about the uCT SiriuX and the even more amped-up uCT SiriuX Ultrix. They’ve snagged the CE mark, a passport to roll out these impressive machines across the continent. Revolutionizing...

Continue Reading
Cypress Wood's Resilience in Louisiana's Humidity

Updated Category News Views 1

Timber Talk with Wes McAdams Diving into the nitty-gritty of building materials isn't everyone's cup of tea, but when you live in a place like Baton Rouge, understanding what stands up to the swampy summer heat is plain survival. The main focus? Cypress wood. Now, Wes McAdams from Cajun Cypress throws his hat into the ring, shedding some light on why cypress might just be...

Continue Reading
Drones Propel Precision Agriculture Market's Skyrocketing Growth

Updated Category News Views 2

Transforming Fields with a Bird's Eye View The old-school way of agricultural surveying is about as appealing as a broken plow in a rainstorm. Trudging across miles of farmland, hoping to spot issues before they turn into wallet-drainers—who's got time for that? Enter drones, the buzzing saviors of the modern farm. These high-tech marvels, loaded with multispectral and...

Continue Reading
Innventure Faces Securities Lawsuit After 74% Stock Drop

Updated Category News Views 2

Innventure's Stunning Plummet: A Lesson in Investor Caution Investors in Innventure, Inc. (NASDAQ: INV) got a harsh reminder of the market's volatility when the company's stock value nosedived by a staggering 74%. From May 27, 2026, just before the forensic bombshell by Morpheus Research, to August 14, 2026, Innventure's stock went from shaky to downright catastrophic....

Continue Reading
Aurra Markets Wins 'Most Transparent Broker' Award 2026

Updated Category News Views 2

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Continue Reading
Eluvio's Broadcast Revolution: Zero-Copy AI Streaming

Updated Category News Views 2

The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...

Continue Reading

Top 5 Most Recently Viewed Articles

Huron Appoints Hope Katz as New General Counsel

Updated Category News Views 129

Huron Welcomes Hope Katz as General Counsel In an exciting development within the legal realm, globe-spanning professional services firm Huron (NASDAQ: HURN) has recently made a significant addition to its executive team. The firm has elevated Hope Katz to the position of executive vice president, general counsel, and corporate secretary, with her new role set to commence...

Continue Reading
Aston Martin's Growth Focus: Key Strategies and Insights Unveiled

Updated Category News Views 164

Aston Martin's Growth Focus: Key Strategies and Insights Unveiled Aston Martin's CEO Adrian Hallmark and CFO Doug Lafferty recently provided valuable insights into the company’s financial performance and future ambitions during an earnings call. Hallmark, who has settled into his role, emphasized the importance of the newly launched Vanquish and shared his excitement...

Continue Reading
Investigation into Possible Violations at Zuora and Others

Updated Category News Views 161

Halper Sadeh LLC's Investigation into Companies Halper Sadeh LLC, an esteemed law firm focused on investor rights, is currently exploring potential violations of federal securities laws involving several companies, including notable names like Zuora, Profire Energy, Future Vision II Acquisition Corp., and Hudson Acquisition I Corp. Details of the Investigations The...

Continue Reading
Navigating Dow Inc. Securities Lawsuit: Key Information for Investors

Updated Category News Views 183

Understanding the Dow Inc. Securities Lawsuit Investors have been notified of an important class action lawsuit involving Dow Inc. (NYSE: DOW). This legal action has been initiated by Levi & Korsinsky, LLP, aimed at protecting the rights of shareholders. This article will break down the essential aspects of the lawsuit and the implications for Dow investors. Who is...

Continue Reading
FDA Clears Momentis Anovo®: Revolution in Surgery

Updated Category News Views 7

The Evolution of Robotic Surgery There's a tide coming in the world of surgery, and Momentis Surgical is right at the crest. This isn't just another corporate cheer; we're talking about the FDA giving a green light to Momentis Surgical's Anovo® System. With this nod, the platform isn't bound by the chains of traditional robotic surgery systems. We're now looking at the...

Continue Reading